Stock Events

Stock Events

Denali Therapeutics (DNLI) Q1 2026 Earnings

26FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.78

-0.75

-0.72

-0.7

Details

Expected EPS

-0.736867

Actual EPS

-0.73

Surprise EPS

0.01

Surprise Percent

+0.93%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.73 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.